Bipolar i disorder Trials in Decatur, United States
Conditions / Bipolar i disorder / Decatur, United States
Research into Bipolar i disorder spans multiple therapeutic approaches and trial phases.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04578756 | Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder | COMPLETED | PHASE3 |
| NCT04777357 | A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder. | RECRUITING | PHASE3 |
| NCT03201757 | Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 | COMPLETED | PHASE3 |
| NCT05648591 | Safety and Tolerability of Open-Labeled Iloperidone in Adolescents | RECRUITING | PHASE4 |
| NCT04987229 | Long-term Safety Extension Study of OLZ/SAM in Pediatric Subjects | ENROLLING_BY_INVITATION | PHASE3 |
| NCT07172516 | A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) | RECRUITING | PHASE3 |
| NCT05303064 | Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder | RECRUITING | PHASE3 |
| NCT01567527 | Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients | COMPLETED | PHASE3 |
| NCT07217860 | An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE) | ENROLLING_BY_INVITATION | PHASE3 |
| NCT03573297 | A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features | COMPLETED | PHASE3 |